DLD Asset Management »

Viking Therapeutics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $390k 10k 39.01
2018-09-30 $2.1M 123k 17.41

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Marathon Digital Holdings In Put Option (MARA)
Eli Lilly & Co. Call Option (LLY)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Encore Cap Group Note 4.000% 3/1 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Super Micro Computer Com New Put Option (SMCI)
Merit Med Sys Note 3.000% 2/0 (Principal)

View all positions for DLD Asset Management

Top funds holding Viking Therapeutics

FMR
BlackRock
Vanguard Capital Management
Susquehanna International
Vanguard Portfolio Management
State Street Corporation
Two Sigma Investments
Morgan Stanley
Citadel Advisors
Ameriprise Financial
Geode Capital Management
Diadema Partners
American Century Companies
Jane Street
D. E. Shaw & Co

View all funds holding Viking Therapeutics